The OHSU Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. The institute’s director, Brian Druker, MD, helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. Driven by its mission to end cancer as we know it, the institute is building upon its expertise in targeted treatments to advance the early detection of cancer when the disease is most treatable.

The OHSU Knight Cancer Institute is the only National Cancer Institute Comprehensive Cancer Center between Sacramento and Seattle – an honor earned only by the nation’s top cancer centers. The Knight Cancer Institute is also the headquarters for the NCI’s SWOG collaborative, a cancer research cooperative group that designs and conducts multidisciplinary clinical trials to improve the practice of medicine for preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors.

Website: ohsu.edu/knight-cancer-institute